These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 798201)

  • 21. [The problem of an antilipemic synergism between the action of nicotinic acid and the sulphated polyanion SP54 (author's transl)].
    Levy H
    Med Klin; 1974 Sep; 69(36):1441-7. PubMed ID: 4280008
    [No Abstract]   [Full Text] [Related]  

  • 22. Does hypolipidemic therapy prevent coronary heart disease?
    Rifkind BM; Levy RI
    Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303
    [No Abstract]   [Full Text] [Related]  

  • 23. Reduction of serum lipids in familial hyperlipidemias by a tetralin derivative.
    Oriente P; Motolese M; Cerqua R; Mancini M
    Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):348-53. PubMed ID: 4903988
    [No Abstract]   [Full Text] [Related]  

  • 24. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate.
    Nye ER; Sutherland WH; Temple Wa
    N Z Med J; 1980 Nov; 92(671):345-9. PubMed ID: 6935550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical evaluation of a new drug (CH 13437) in the treatment of hyperlipemia].
    Arteaga A; Foradori A; Eyzaguirre J; Lira P; Vasquez A; Soto S; Alliende ME; Guzman L
    Rev Med Chil; 1970 Oct; 98(10):689-94. PubMed ID: 4927028
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical trials with Fonlipol. Apropos of 50 cases].
    Warembourg H; Jaillard J
    Lille Med; 1974 Apr; 19(4 Suppl 11):528-31. PubMed ID: 4612282
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hypolipidemic activity of glycine and its derivatives].
    Ryzhenkov VE; Molokovskiĭ DS; Ioffe DV
    Vopr Med Khim; 1984; 30(2):78-80. PubMed ID: 6740998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipokinetic studies with gemfibrozil (CI-719).
    Kissebah AH; Adams PA; Wynn V
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):94-7. PubMed ID: 190610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gemfibrozil therapy in patients with coronary heart disease.
    Bell H; Dittmeier G; Martinez L
    Mo Med; 1988 Jan; 85(1):27-30. PubMed ID: 3277032
    [No Abstract]   [Full Text] [Related]  

  • 30. [The clinical use of bis-(hydroxy-ethyl-thio)-1,10-decane in the treatment of hyperlipemic and dyslipemic conditions].
    Vailati G; Montini M; Simonutti M; Nosari I; Pagani G
    Clin Ter; 1978 May; 85(4):361-73. PubMed ID: 668273
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapeutic trial of a normolipemic agent: ethanolamine N-oxy-nicotinate].
    Warembourg H; Ketelers JY; Ginestet A
    Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1331-5. PubMed ID: 4608970
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experimental and clinical studies on the hypolipemic action of 1,5-dicaffeoylquinic acid].
    Wójcicki J; Bobnis W; Olszewska M; Szmatloch E
    Pol Tyg Lek; 1974 Apr; 29(15):627-9. PubMed ID: 4828046
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapy of hyperlipidemia. Clinical experience with clinofibrate].
    Avellone G; Di Garbo V; Strano A
    Clin Ter; 1989 Apr; 129(1):25-9. PubMed ID: 2525449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Halofenate: an effective hypolipemia- and hypouricemia-inducing drug.
    Aronow WS; Vangrow JS; Nelson WH; Pagano J; Papageorge's NP; Khursheed M; Harding PR; Khemka M
    Curr Ther Res Clin Exp; 1973 Dec; 15(12):902-6. PubMed ID: 4203573
    [No Abstract]   [Full Text] [Related]  

  • 35. Hypolipidaemic effect of xantinol nicotinate: a clinical trial.
    Dhorranintra B; Khunawat P; Patalung BN; Prabhan C
    J Med Assoc Thai; 1983 May; 66(5):269-73. PubMed ID: 6348198
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of primary hyperlipidemia with 5-methylpyrazinecarboxylic acid (acipimox)].
    Quintão EC; de Castilho LN
    Arq Bras Cardiol; 1985 Jan; 44(1):37-40. PubMed ID: 4062591
    [No Abstract]   [Full Text] [Related]  

  • 37. [Indications and limitations of tiadenol therapy of dyslipidemia in the elderly].
    Passeri M; Cocchi C; Ceccato S; Palummeri E; Cucinotta D
    G Clin Med; 1979 Jan; 60(1):49-64. PubMed ID: 456778
    [No Abstract]   [Full Text] [Related]  

  • 38. Toleration and bioavailability of gemfibrozil in healthy men.
    Smith TC
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):24-7. PubMed ID: 798193
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical-experimental studies on lipid metabolism using Regelan].
    Hammerl H
    Wien Klin Wochenschr; 1967 Sep; 79(39):720-2. PubMed ID: 4875575
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical research into the hypolipemic and platelet antiaggregant activity of plafibride, Carried out in double-blind conditions and in comparison with clofibrate.
    Palmieri B; Gasparini Casari M; DiBlasio P; Zirilli E
    Arzneimittelforschung; 1981; 31(10a):1863-6. PubMed ID: 7032534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.